ConductScience.org, home

Paper37765331

Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.

Viegas C and 6 others. Pharmaceutics, 2023. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems. Papers, record 37765331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37765331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.
PubMed
Journal
Pharmaceutics
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
4.26
iCite
Revised in PubMed
2024-09-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Viegas CCláudiahttps://orcid.org/0000-0001-6668-2778
2Patrício ABAna B
3Prata JJoão
4Fonseca LLeonor
5Macedo ASAna S
6Duarte SODSofia O Dhttps://orcid.org/0000-0002-7945-1474
7Fonte PPedrohttps://orcid.org/0000-0002-1115-9282

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
UIDB/04326/2020Fundação para a Ciência e TecnologiaPubMed
UIDP/04326/2020Fundação para a Ciência e TecnologiaPubMed
LA/P/0101/2020Fundação para a Ciência e TecnologiaPubMed
UIDB/04565/2020Fundação para a Ciência e TecnologiaPubMed
UIDP/04565/2020Fundação para a Ciência e TecnologiaPubMed
LA/P/0140/2020Fundação para a Ciência e TecnologiaPubMed
2020.08839.BDFundação para a Ciência e TecnologiaPubMed

Source PubMed

Download CSV of grants

References183

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120198462Pancreatic cancer: pathobiology, treatment options, and drug delivery.AAPS J2010https://conductscience.org/library/papers/20198462PubMed
221412497Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.World J Gastroenterol2011https://conductscience.org/library/papers/21412497PubMed
325099181Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.BMC Endocr Disord2014https://conductscience.org/library/papers/25099181PubMed
424871552The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.AAPS PharmSciTech2014https://conductscience.org/library/papers/24871552PubMed
525273092Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion.Cancer Res2014https://conductscience.org/library/papers/25273092PubMed
629662668Proteomic biomarkers in body fluids associated with pancreatic cancer.Oncotarget2018https://conductscience.org/library/papers/29662668PubMed
724163786Paclitaxel Nano-Delivery Systems: A Comprehensive Review.J Nanomed Nanotechnol2013https://conductscience.org/library/papers/24163786PubMed
86141560Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6141560PubMed
92482253Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.Gastroenterol Clin North Am1989https://conductscience.org/library/papers/2482253PubMed
1025319803Stimuli-responsive polymeric nanoparticles for nanomedicine.ChemMedChem2015https://conductscience.org/library/papers/25319803PubMed
1126812903European cancer mortality predictions for the year 2016 with focus on leukaemias.Ann Oncol2016https://conductscience.org/library/papers/26812903PubMed
1232208984Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in vitro studies.Drug Dev Ind Pharm2020https://conductscience.org/library/papers/32208984PubMed
1330999154Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.Biomaterials2019https://conductscience.org/library/papers/30999154PubMed
1421969517Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.J Clin Oncol2011https://conductscience.org/library/papers/21969517PubMed
1528850089Magnetic Nanoparticles: From Design and Synthesis to Real World Applications.Nanomaterials (Basel)2017https://conductscience.org/library/papers/28850089PubMed
1627299311Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Pharm Res2016https://conductscience.org/library/papers/27299311PubMed
1726185420Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.Drug Des Devel Ther2015https://conductscience.org/library/papers/26185420PubMed
1827531700Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Nat Rev Clin Oncol2016https://conductscience.org/library/papers/27531700PubMed
1927284250Onivyde for the therapy of multiple solid tumors.Onco Targets Ther2016https://conductscience.org/library/papers/27284250PubMed
2022425961Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Cancer Lett2012https://conductscience.org/library/papers/22425961PubMed

See all 183 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42873039From Nature to Medicine: Overcoming the Limitations of Herbal Therapeutics for Pancreatic Cancer Treatment Based on Nanotechnology.Nanomaterials (Basel)2026https://conductscience.org/library/papers/42873039PubMed
42816651Inhibition of pancreatic cancer growth by an siRNA targeting SNORA22 and a folic acid-conjugated cationic oligopeptide.Hum Cell2026https://conductscience.org/library/papers/42816651PubMed
42639199Ferroptosis-Based Nanotherapy for Pancreatic Ductal Adenocarcinoma Through Glutathione Depletion and Iron Accumulation.Int J Nanomedicine2026https://conductscience.org/library/papers/42639199PubMed
42215504The cationic nanoliposomes loaded with asymmetric PCR product targeting PTK6 mRNA and induce apoptosis in PANC-1 cells.Sci Rep2026https://conductscience.org/library/papers/42215504PubMed
42120783Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management.AAPS PharmSciTech2026https://conductscience.org/library/papers/42120783PubMed
42062704uPAR-targeted stealth small-sized mesoporous silica nanoparticles for pancreatic cancer therapy.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42062704PubMed
41869550Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer.Smart Mater Med2025https://conductscience.org/library/papers/41869550PubMed
41580747Recent advances in nanomaterial-based precision medicine for orthotopic tumor therapy.J Nanobiotechnology2026https://conductscience.org/library/papers/41580747PubMed
41293487Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer.Mater Today Bio2025https://conductscience.org/library/papers/41293487PubMed
41219654Utilizing Hot-Melt Extrusion and Spray Drying Techniques for Preparation of Liquid and Solid Cannabidiol Nano-Structured Lipid Carriers Formulations.AAPS PharmSciTech2025https://conductscience.org/library/papers/41219654PubMed
40917849Nanotechnology and natural killer cell immunotherapy: synergistic approaches for precise immune system adjustment and targeted cancer treatment in gastrointestinal tumors.Front Med (Lausanne)2025https://conductscience.org/library/papers/40917849PubMed
40859982Panobinostat-Loaded Albumin Nanoparticles for the Treatment of Pancreatic Cancer.J Drug Deliv Sci Technol2025https://conductscience.org/library/papers/40859982PubMed
40801679Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.Nanomaterials (Basel)2025https://conductscience.org/library/papers/40801679PubMed
40720073Redox Signaling Disruption and Antioxidants in Toxicology: From Precision Therapy to Potential Hazards.Cell Biochem Biophys2025https://conductscience.org/library/papers/40720073PubMed
40699702Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699702PubMed
40585000Riding the wave of innovation: nanotechnology in nucleic acid-based cancer therapy.3 Biotech2025https://conductscience.org/library/papers/40585000PubMed
40547806An overview of the feasibility of nanomedicine in pancreatic cancer theranostics.Explor Target Antitumor Ther2025https://conductscience.org/library/papers/40547806PubMed
40202672Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40202672PubMed
39682281Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications.Cancers (Basel)2024https://conductscience.org/library/papers/39682281PubMed
39331254The antioxidant and selective apoptotic activities of modified auraptene-loaded graphene quantum dot nanoparticles (M-AGQD-NP).Discov Oncol2024https://conductscience.org/library/papers/39331254PubMed

See all 23 cited byDownload CSV of cited by

Genes63

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
ARID2196528PubTator's text mininghttps://conductscience.org/library/genes/196528NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CCK885PubTator's text mininghttps://conductscience.org/library/genes/885NCBI Gene
CCNG1900PubTator's text mininghttps://conductscience.org/library/genes/900NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CHGA1113PubTator's text mininghttps://conductscience.org/library/genes/1113NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EPC180314PubTator's text mininghttps://conductscience.org/library/genes/80314NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene

See all 63 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37765331

GET https://conductscience.org/api/papers/v1/37765331/references?page=2